Levi & Korsinsky notifies investors that it has commenced an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) concerning potential violations of the federal securities laws.
The Hunterbrook report alleged that ENSG inflated CMS star ratings -- a key metric that drives reimbursement rates and investor confidence. On the Company's Q1 2026 earnings call on May 1, 2026, CEO Barry Port stated that "85% of all of our operations are at 4- or 5-star quality measures." The short-seller report directly challenged the accuracy of those quality metrics, alleging that the ratings were the product of systematic data manipulation rather than genuine clinical performance. The report also alleged improper related-party billing practices at the company's network of skilled nursing facilities. Prior to the report's publication, on June 2, 2026, a director filed a Form 144 attesting that "he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The stock declined sharply in the session following the Hunterbrook publication.
If you suffered a loss on your The Ensign Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





